A Sustainable Guide to Better Metabollic Health
“As of 2026, the medical community’s view on using Ozempic for weight loss has shifted, recognizing obesity, a chronic, relapsing disease rather than a failure of willpower. Central to this shift is the rise of GLP-1 receptor agonists like Ozempic (semaglutide). While these medications offer a powerful “metabolic assist,” licensed nutritionists and dietitians emphasize that they are most effective when used as a tool within a broader framework of sustainable living.
Who Should Use Ozempic for Weight Loss?
According to the World Health Organization (WHO) 2025/2026 Global Guidelines, Ozempic and similar therapies are recommended specifically for individuals at significant health risk. This includes:
- Individuals with a BMI of 30 or higher (Classified as obesity).
- Individuals with a BMI of 27 or higher who also present at least one weight-related comorbidity, such as Type 2 diabetes, hypertension, or high cholesterol.
“It is important to remember that obesity is heterogeneous, chronic and complex,” says Dr. Vijaya Surampudi, Physician Nutrition Specialist and Assistant Director of the UCLA Weight Management Program. “There is no cure for obesity; it requires lifelong treatment that’s not one-size-fits-all.”
Ozempic is not intended for “cosmetic” weight loss. It is a serious medical intervention for those whose weight poses an immediate threat to their long-term health.
The “Nutritionist-First” Approach to Fat Los
Licensed Registered Dietitian Nutritionists (RDNs) are now considered essential partners in GLP-1 therapy. Because Ozempic slows gastric emptying and reduces appetite, what you eat becomes more critical than how much you eat.
Prioritizing Nutrient Density
The goal is to lose fat mass, not just “weight.” To achieve this, nutritionists recommend a “Protein-First” strategy to prevent muscle wasting (sarcopenia), which can account for up to 40% of weight lost on GLP-1s if not managed.
| Nutrient | Recommended Focus | Why It Matters |
| Protein | 1.2–1.6g per kg of body weight | Preserves lean muscle mass and boosts metabolic rate. |
| Fiber | 25–35g daily | Supports gut health and helps manage GI side effects. |
| Hydration | 80+ oz of water | Prevents nausea and supports kidney function. |
| Whole Foods | Leafy greens, berries, lean poultry, legumes | Provides micronutrients that may be missed during low-calorie intake. |
Targeted Fat Loss: Can You “Blast” Belly Fat?
A common question is whether Ozempic can specifically target belly fat. While “spot reduction” is biologically impossible, Ozempic is highly effective at reducing visceral fat—the dangerous fat stored around internal organs in the abdominal cavity.
Dr. Paunel Vukasinov, an internist and obesity medicine specialist, notes:
“Clinical trials show semaglutide reduces both visceral and subcutaneous fat proportionally across the body… reducing waist circumference and improving insulin resistance.”
To maximize belly fat loss, nutritionists suggest:
- Eliminating Ultra-Processed Sugars: High insulin levels (driven by sugar) signal the body to store fat in the midsection.
- Cortisol Management: Stress hormones can lead to abdominal fat accumulation. Sustainable living includes prioritizing 7–9 hours of sleep and stress-reduction techniques like mindful breathing.
The Sustainable Living Framework: Beyond the Needle
The “Ozempic plateau” is a well-documented phenomenon occurring around the 6-to-9-month mark. To maintain progress and ensure health if the medication is eventually discontinued, RDNs advocate for these core habits:
1. Progressive Resistance Training
Muscle is your most metabolically active tissue. To prevent the “Ozempic Body” (a hollowed or frail appearance), experts recommend 2–3 sessions of strength training per week. Focusing on compound movements like squats, rows, and presses stimulates muscle protein synthesis.
2. Mindful Eating Habits
Because hunger signals are chemically suppressed, it’s easy to under-eat or forget to eat, leading to fatigue.
- Eat little and often: Smaller, frequent meals prevent the extreme “fullness” discomfort.
- Savor every bite: Mindful eating helps you relearn satiety cues that will be vital if you ever transition off the medication.
Citations and Scientific References
- World Health Organization (WHO), 2025. Global Guideline on the use of GLP-1 therapies for treating obesity.
- Wilding, J. P. H., et al. (STEP 1 Study Group). “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine.
- UCLA Health, 2026. “Semaglutide for weight loss: what you need to know,” featuring insights from Dr. Vijaya Surampudi.
- Institute for Clinical and Economic Review (ICER), 2025. Final Evidence Report on GLP-1 Receptor Agonists for Obesity Management.
- Cleveland Clinic, 2025. GLP-1 Diet: What To Eat & Avoid While on Semaglutide.
